MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 2, 2010, Pages 158-165

  Sy, Hiu Ngar ^a   Wu, Shey Lin ^a,b   Wang, Wen Fu ^a   Chen, Chang Hao ^c   Huang, Yao Ting ^a   Liou, Ying Ming ^d   Chiou, Chien Shun ^e   Pawlak, Cornelius Rainer ^f,g   Ho, Ying Jui ^c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b DA YEH UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e CENTER FOR DISEASE CONTROL   (Taiwan)

^f CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^g GOETHE UNIVERSITY   (Germany)

Author keywords

Dementia; Microglial activation; MPTP; Neuroinflammation; Object recognition; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CELL ACTIVATION; CELL LOSS; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DOPAMINERGIC NERVE CELL; ENCEPHALITIS; HIPPOCAMPUS; MALE; MICROGLIA; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; ENCEPHALITIS; HIPPOCAMPUS; MPTP POISONING; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 76949094169     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.12.020     Document Type: Article

References (75)

1. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., and Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 56 (2001) 730-736
2. Aarsland D., Zaccai J., and Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 20 (2005) 1255-1263
3. Abramsky O., and Litvin Y. Autoimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Perspect Biol Med 22 (1978) 104-114
4. Baker K.B., and Kim J.J. Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats. Learn Mem 9 (2002) 58-65
5. Barnes J., Boubert L., Harris J., Lee A., and David A.S. Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia 41 (2003) 565-574
6. Bernal F., Saura J., Ojuel J., and Mahy N. Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity. Exp Neurol 161 (2000) 686-695
7. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4 (2001) 702-710
8. Broadbent N.J., Squire L.R., and Clark R.E. Spatial memory, recognition memory, and the hippocampus. Proc Natl Acad Sci U S A 101 (2004) 14515-14520
9. Brown R.G., and Marsden C.D. How common is dementia in Parkinson's disease?. Lancet 2 (1984) 1262-1265
10. Capitelli C., Sereniki A., Lima M.M., Reksidler A.B., Tufik S., and Vital M.A. Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats. Eur J Pharmacol 594 (2008) 101-108
11. Caraceni A., Martini C., Belli F., Mascheroni L., Rivoltini L., Arienti F., et al. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. Eur J Cancer 29A (1993) 1266-1269
12. Clarke J.R., Rossato J.I., Monteiro S., Bevilaqua L.R., Izquierdo I., and Cammarota M. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiol Learn Mem 90 (2008) 374-381
13. Costa M.S., Botton P.H., Mioranzza S., Ardais A.P., Moreira J.D., Souza D.O., et al. Caffeine improves adult mice performance in the object recognition task and increases BDNF and TrkB independent on phospho-CREB immunocontent in the hippocampus. Neurochem Int 53 (2008) 89-94
14. Crucian G.P., and Okun M.S. Visual-spatial ability in Parkinson's disease. Front Biosci 8 (2003) s992-s997
15. Da Cunha C., Gevaerd M.S., Vital M.A., Miyoshi E., Andreatini R., Silveira R., et al. Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia. Behav Brain Res 124 (2001) 9-18
16. Da Cunha C., Angelucci M.E., Canteras N.S., Wonnacott S., and Takahashi R.N. The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. Cell Mol Neurobiol 22 (2002) 227-237
17. Da Cunha C., Wietzikoski S., Wietzikoski E.C., Miyoshi E., Ferro M.M., Anselmo-Franci J.A., et al. Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system. Neurobiol Learn Mem 79 (2003) 236-242
18. de Lima M.N., Luft T., Roesler R., and Schroder N. Temporary inactivation reveals an essential role of the dorsal hippocampus in consolidation of object recognition memory. Neurosci Lett 405 (2006) 142-146
19. Denicoff K.D., Rubinow D.R., Papa M.Z., Simpson C., Seipp C.A., Lotze M.T., et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107 (1987) 293-300
20. Dheen S.T., Kaur C., and Ling E.A. Microglial activation and its implications in the brain diseases. Curr Med Chem 14 (2007) 1189-1197
21. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2 (2003) 229-237
22. Fenelon G., Mahieux F., Huon R., and Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123 Pt 4 (2000) 733-745
23. Ferro M.M., Bellissimo M.I., Anselmo-Franci J.A., Angellucci M.E., Canteras N.S., and Da Cunha C. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations. J Neurosci Methods 148 (2005) 78-87
24. Garcia A.M., Cardenas F.P., and Morato S. Effect of different illumination levels on rat behavior in the elevated plus-maze. Physiol Behav 85 (2005) 265-270
25. Gilbert P.E., and Kesner R.P. The role of the dorsal CA3 hippocampal subregion in spatial working memory and pattern separation. Behav Brain Res 169 (2006) 142-149
26. Girotti F., Soliveri P., Carella F., Piccolo I., Caffarra P., Musicco M., et al. Dementia and cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiat 51 (1988) 1498-1502
27. Hammond R.S., Tull L.E., and Stackman R.W. On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 82 (2004) 26-34
28. Hirohata M., Ono K., Morinaga A., and Yamada M. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. Neuropharmacology 54 (2008) 620-627
29. Ho Y.J., Eichendorff J., and Schwarting R.K. Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behav Brain Res 136 (2002) 1-12
30. Ho Y.J., Hsu L.S., Wang C.F., Hsu W.Y., Lai T.J., Hsu C.C., et al. Behavioral effects of d-cycloserine in rats: the role of anxiety level. Brain Res 1043 (2005) 179-185
31. Hunsaker M.R., Thorup J.A., Welch T., and Kesner R.P. The role of CA3 and CA1 in the acquisition of an object-trace-place paired-associate task. Behav Neurosci 120 (2006) 1252-1256
32. Hunsaker M.R., Lee B., and Kesner R.P. Evaluating the temporal context of episodic memory: the role of CA3 and CA1. Behav Brain Res 188 (2008) 310-315
33. Imamura K., Hishikawa N., Sawada M., Nagatsu T., Yoshida M., and Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol 106 (2003) 518-526
34. Imamura K., Hishikawa N., Ono K., Suzuki H., Sawada M., Nagatsu T., et al. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol 109 (2005) 141-150
35. Jara J.H., Singh B.B., Floden A.M., and Combs C.K. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J Neurochem 100 (2007) 1407-1420
36. Kadiu I., Glanzer J.G., Kipnis J., Gendelman H.E., and Thomas M.P. Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases. Neurotox Res 8 (2005) 25-50
37. Klegeris A., and McGeer P.L. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res 2 (2005) 355-365
38. Laatu S., Revonsuo A., Pihko L., Portin R., and Rinne J.O. Visual object recognition deficits in early Parkinson's disease. Parkinsonism Relat Disord 10 (2004) 227-233
39. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
40. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., and Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine exposure. Ann Neurol 46 (1999) 598-605
41. Levin B.E., Llabre M.M., Reisman S., Weiner W.J., Sanchez-Ramos J., Singer C., et al. Visuospatial impairment in Parkinson's disease. Neurology 41 (1991) 365-369
42. Levy G., Tang M.X., Louis E.D., Cote L.J., Alfaro B., Mejia H., et al. The association of incident dementia with mortality in PD. Neurology 59 (2002) 1708-1713
43. Lewis S.J., Slabosz A., Robbins T.W., Barker R.A., and Owen A.M. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 43 (2005) 823-832
44. Li J.S., and Chao Y.S. Electrolytic lesions of dorsal CA3 impair episodic-like memory in rats. Neurobiol Learn Mem 89 (2008) 192-198
45. Liu Y., Wong T.P., Aarts M., Rooyakkers A., Liu L., Lai T.W., et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci 27 (2007) 2846-2857
46. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21 (1995) 195-218
47. McGeer P.L., and McGeer E.G. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10 Suppl 1 (2004) S3-S7
48. McGeer P.L., Itagaki S., Boyes B.E., and McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38 (1988) 1285-1291
49. Meissner W., Prunier C., Guilloteau D., Chalon S., Gross C.E., and Bezard E. Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease. Mol Neurobiol 28 (2003) 209-218
50. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., and Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett 211 (1996) 13-16
51. Mumby D.G., Tremblay A., Lecluse V., and Lehmann H. Hippocampal damage and anterograde object-recognition in rats after long retention intervals. Hippocampus 15 (2005) 1050-1056
52. Ogura K., Ogawa M., and Yoshida M. Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. NeuroReport 5 (1994) 1224-1226
53. Owen A.M., Sahakian B.J., Hodges J.R., Summers B.A., Polkey C.E., and Robbins T.W. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology 9 (1995) 126-140
54. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, London
55. Perry J.C., Hipolide D.C., Tufik S., Martins R.D., Da Cunha C., Andreatini R., et al. Intra-nigral MPTP lesion in rats: behavioral and autoradiography studies. Exp Neurol 195 (2005) 322-329
56. Piekema C., Kessels R.P., Mars R.B., Petersson K.M., and Fernandez G. The right hippocampus participates in short-term memory maintenance of object-location associations. Neuroimage 33 (2006) 374-382
57. Ramirez-Ruiz B., Junque C., Marti M.J., Valldeoriola F., and Tolosa E. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations. Mov Disord 21 (2006) 1483-1487
58. Rampon C., Tang Y.P., Goodhouse J., Shimizu E., Kyin M., and Tsien J.Z. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat Neurosci 3 (2000) 238-244
59. Reksidler A.B., Lima M.M., Dombrowski P., Andersen M.L., Zanata S.M., Andreatini R., et al. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease. J Neurosci Meth 167 (2008) 268-277
60. Rosi S., Vazdarjanova A., Ramirez-Amaya V., Worley P.F., Barnes C.A., and Wenk G.L. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience 142 (2006) 1303-1315
61. Sanberg P.R., Bunsey M.D., Giordano M., and Norman A.B. The catalepsy test: its ups and downs. Behav Neurosci 102 (1988) 748-759
62. Sawada M., Imamura K., and Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl (2006) 373-381
63. Schneider J.S., Tinker J.P., Van Velson M., and Giardiniere M. Effects of the partial glycine agonist d-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys. Brain Res 860 (2000) 190-194
64. Sedelis M., Schwarting R.K., and Huston J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 125 (2001) 109-125
65. Shi L., Adams M.M., Long A., Carter C.C., Bennett C., Sonntag W.E., et al. Spatial learning and memory deficits after whole-brain irradiation are associated with changes in NMDA receptor subunits in the hippocampus. Radiat Res 166 (2006) 892-899
66. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., and O'Callaghan J.P. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J 20 (2006) 670-682
67. Stern Y., Tetrud J.W., Martin W.R., Kutner S.J., and Langston J.W. Cognitive change following MPTP exposure. Neurology 40 (1990) 261-264
68. Tanaka S., Ide M., Shibutani T., Ohtaki H., Numazawa S., Shioda S., et al. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res 83 (2006) 557-566
69. Wang A.L., Liou Y.M., Pawlak C.R., and Ho Y.J. Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats. Behavior Brain Res 208 (2010) 38-46
70. Wang WF, Wu SL, Liou YM, Wang AL, Pawlak CR, Ho YJ. MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats. Behav. Neurosci. 2009;123:1261-70.
71. West W.H., Tauer K.W., Yannelli J.R., Marshall G.D., Orr D.W., Thurman G.B., et al. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316 (1987) 898-905
72. Wood E.R., Mumby D.G., Pinel J.P., and Phillips A.G. Impaired object recognition memory in rats following ischemia-induced damage to the hippocampus. Behav Neurosci 107 (1993) 51-62
73. Wu S.L., Hsu L.S., Tu W.T., Wang W.F., Huang Y.T., Pawlak C.R., et al. Effects of d-cycloserine on the behavior and ERK activity in the amygdala: role of individual anxiety levels. Behav Brain Res 187 (2008) 246-253
74. Xavier L.L., Viola G.G., Ferraz A.C., Da Cunha C., Deonizio J.M., Netto C.A., et al. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res Protoc 16 (2005) 58-64
75. Zhang W.N., Pothuizen H.H., Feldon J., and Rawlins J.N. Dissociation of function within the hippocampus: effects of dorsal, ventral and complete excitotoxic hippocampal lesions on spatial navigation. Neuroscience 127 (2004) 289-300